|
Real-time
Boerse Muenchen
03:13:30 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 6.150 EUR | 0.00% |
|
+1.65% | +66.22% |
| 09-02 | Knight Therapeutics Gets Regulatory Approval for TAVALISSE in Colombia | MT |
| 09-01 | Knight Therapeutics Announces Regulatory Approval of Tavalisse in Colombia | CI |
Chart: Technical Analysis
Boerse MuenchenEUR
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| GUD | Delayed | |
OTC Markets
| KHTRF | Delayed | |
|
Deutsche Boerse AG
| 04K | Delayed | |
|
Tradegate
| 04K | Real-time | |
|
Boerse Muenchen
| 04K | Real-time | |
|
Börse Stuttgart
| 04K | Delayed |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GUD Stock
- 04K Stock
- Charts Knight Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
